Open original FDA record ↗Recall record
- FDA identifier
- Z-1583-2023
- Company in FDA record
- Greiner Bio-One North America, Inc.
- FDA classification date
- May 12, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Some of the tubes may be incorrectly labeled.
Source facts
- Action
- The recalling firm issued a letter dated 3/30/2023 on 3/31/2023 via email to their sole customer. The letter provided the reason for recall, contained detailed information regarding the complaint, provided photographs of the product which included incorrect tube labels and correct tube labels, investigation results, health risk analysis, and actions to be taken. Those actions included to discontinue use of the product immediately and isolate it, assess the risks and consequences of the use of the defective product in accordance with the customer's procedures and take appropriate action, and complete the attached Product Disposition Site Confirmation. The customer is to record the amount of product they have destroyed on the form and return it via FAX or email. It also instructs that if the customer has distributed this product elsewhere, they are requested to provide the recalling firm with the contact information for follow-up.
- Initiated
- 2023-03-31
- Root cause
- Labeling Change Control
- Distribution
- US Nationwide distribution in the states of WI and GA.
- Recall number
- Z-1583-2023
- Recall status
- Completed
- CDRH record ID
- 199435
- FDA classified
- 2023-05-12
- Recall event number
- 92025